| ||||||||||||||||||||||||||||||||||||||||||||||||||||||
© Oxford University Press 2008.
In This Issue
| The first 10% of the full text of this article appears below. |
Costs and Effectiveness of Breast Cancer Screening in India
In developing nations, with lower but increasing rates of breast cancer and fewer economic resources than wealthier nations, the cost-effectiveness of breast cancer screening programs is a critical issue. To estimate the costs of potential programs for breast cancer screening in India that were based on either mammography or clinical breast examination, Lamberts Okonkwo et al. (p. 1290) applied a MISCAN (MIcrosimulation SCreening ANalysis) model of breast cancer that was calibrated to data on breast cancer incidence, stage distribution, and mortality in that country. They found that clinical breast examination in women aged 40–60 (whether done
Survival Among US Children with Hematologic Malignancies
Adequacy of Nodal Evaluation of Patients with Colon Cancer
Little Bias in Familial Cancer Risk Estimates for Common Cancers
NCI Summit on Gastroenteropancreatic Neuroendocrine Tumors
Sequence Variants at 15q and Risk of Familial Lung Cancer
Related Articles in JNCI
![]()
CiteULike
Connotea
Del.icio.us What's this?
J Natl Cancer Inst 2008 100: 1326-1330.
J Natl Cancer Inst 2008 100: 1282-1289.
J Natl Cancer Inst 2008 100: 1301-1309.
J Natl Cancer Inst 2008 100: 1318-1325.
J Natl Cancer Inst 2008 100: 1290-1300.
J Natl Cancer Inst 2008 100: 1310-1317.
J Natl Cancer Inst 2008 100: 1270-1271.
J Natl Cancer Inst 2008 100: 1271-1273.